Prelude Therapeutics (PRLD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Prelude Therapeutics

    NASDAQ: PRLD · Real-Time Price · USD
    1.25
    0.02 (1.63%)
    At close: Sep 08, 2025, 3:59 PM
    1.25
    0.00%
    After-hours: Sep 08, 2025, 04:10 PM EDT

    Prelude Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 7M n/a n/a n/a
    Cost of Revenue
    		 1.77M 1.17M 3.04M 2.24M
    Gross Profit
    		 7M -1.17M -3.04M -2.24M
    Operating Income
    		 -139.71M -132.28M -123.54M -113.73M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -127.17M -121.83M -115.44M -111.69M
    Net Income
    		 -127.17M -121.83M -107.34M -110.78M
    Selling & General & Admin
    		 28.72M 28.88M 30.65M 26.96M
    Research & Development
    		 118M 103.39M 92.89M 86.78M
    Other Expenses
    		 n/a n/a 8.1M 2.04M
    Operating Expenses
    		 146.71M 132.28M 123.54M 113.73M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 146.71M 132.28M 123.54M 113.73M
    Income Tax Expense
    		 n/a n/a -8.1M -915K
    Shares Outstanding (Basic)
    		 75.81M 60.36M 47.37M 47.6M
    Shares Outstanding (Diluted)
    		 75.81M 60.36M 47.37M 47.6M
    EPS (Basic)
    		 -1.68 -2.02 -2.27 -2.33
    EPS (Diluted)
    		 -1.68 -2.02 -2.27 -2.33
    EBITDA
    		 -139.71M -131.11M -122.22M -112.82M
    EBIT
    		 -139.71M -132.28M -123.54M -113.73M
    Depreciation & Amortization
    		 1.77M 1.17M 3.04M 2.24M

    Add to Watchlist